経皮皮膚パッチの世界市場機会と2032年までの戦略Including：1) 製品別製品別：マトリックス、粘着剤入り薬剤、リザーバー、蒸気2) タイプ別：フェンタニル経皮吸収パッチ、ニコチン経皮吸収パッチ、エストラジオ経皮吸収パッチフェンタニル経皮吸収パッチ；ニコチン経皮吸収パッチ；エストラジオール経皮吸収パッチ；クロニジン経皮吸収パッチ；テストステロン経皮吸収パッチ3）流通チャネル別：疼痛緩和; ニコチン禁煙; ホルモン補充療法; 神経疾患; 循環器疾患; その他の用途Covering：ノバルティス; 久光製薬; 河南霊瑞医薬; テバ・ファーマシューティカルズ; Luye Pharma Group Ltd

Transdermal Skin Patches Global Market Opportunities And Strategies To 2032Including: 1) By Product: Matrix; Drug In Adhesive; Reservoir; Vapor2) By Type: Fentanyl Transdermal Patch; Nicotine Transdermal Patch; Estradiol Transdermal Patch; Clonidine Transdermal Patch; Testosterone Transdermal Patch3) By Distribution Channel: Pain Relief; Nicotine Cessation; Hormone Replacement Therapy; Neurological Disorders; Cardiovascular Disorders; Other ApplicationsCovering: Novartis; Hisamitsu Pharmaceutical Co., Inc; Henan Lingrui Pharmaceutical; Teva Phamaceuticals; Luye Pharma Group Ltd

この調査レポートは、経皮吸収型皮膚パッチの世界市場 2032年までのビジネスチャンスと戦略を掲載し、COVID-19の閉鎖から立ち上がる世界の経皮吸収型皮膚パッチ市場を評価するために必要な重要情報を提供します。... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年5月19日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	356	英語

サマリー

この調査レポートは、経皮吸収型皮膚パッチの世界市場 2032年までのビジネスチャンスと戦略を掲載し、COVID-19の閉鎖から立ち上がる世界の経皮吸収型皮膚パッチ市場を評価するために必要な重要情報を提供します。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスからどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように浮上し、成長する可能性があるのかを理解する。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定します。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。

説明
経皮吸収型皮膚パッチの最大かつ急成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後の市場を形成する勢力は何か？この調査レポートは経皮吸収型皮膚パッチの世界市場を分析・予測したThe Business Research Companyの市場調査報告書です。

当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略を網羅しています。地域別に市場の過去および予測成長を追跡しています。経皮吸収型テープ製剤市場全体の中で同市場を位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています：
-序論と市場特性
経皮吸収型テープ製剤市場について、市場区分、定義、解説を簡単に紹介しています。
-主要動向
経皮吸収型テープ製剤の世界市場を形成している主なトレンドを紹介します。また、今後の市場動向についても解説します。
-世界の市場規模と成長
世界の過去（2017年～2022年）、予測（2022年～2027年）、（2027年～2032年）市場価値、過去および予測期間における市場の成長を支え、コントロールする促進要因と抑制要因について紹介します。
-地域別分析
地域別の過去（2017-2022年）、予測（2022-2027年）、（2027-2032年）市場価値と成長率、市場シェア比較。
-市場セグメンテーション
市場における製品別、タイプ別、用途別の市場価値（2017年～2032年）と各セグメントの分析を収録。
-地域別市場規模と成長
地域別の市場規模（2022年）、過去（2017年～2022年）および予測（2022年～2027年）、（2027年～2032年）の市場価値、地域内各国の成長率と市場シェア比較。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
-競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
-主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を提供します。
-市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を記載しています。
-結論と提言
経皮吸収型テープ製剤を提供する企業に対して、製品・サービスの提供地域拡大、マーケティング戦略、ターゲット層などに関する提言を掲載しています。
-付録
このセクションには、本レポートで使用されているNAICSコード、略語、通貨コードの詳細が含まれています。

スコープ

対象市場
1) 製品別マトリックス; 粘着剤入り薬剤; リザーバー; 蒸気
2) タイプ別フェンタニル経皮パッチ；ニコチン経皮パッチ；エストラジオール経皮パッチ；クロニジン経皮パッチ；テストステロン経皮パッチ；その他のタイプ
3) 販売チャネル別疼痛緩和；ニコチン禁煙；ホルモン補充療法；神経疾患；心血管疾患；その他の用途

言及された企業ノバルティス；久光製薬；河南菱瑞医薬；テバ・ファーマシューティカルズ；Luye Pharma Group Ltd.

国名中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、経皮皮膚パッチ指標比較。

データ区分: 国別および地域別の過去データと予測データ; 競合企業の市場シェア; 市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

当レポートでは、経皮吸収型皮膚パッチ市場について記載・解説し、2017-2022年を過去期間、2022-2027年を予測期間とし、2027-2032年のさらなる予測を加えています。各地域および各地域内の主要経済圏の市場を評価しています。

経皮皮膚パッチの世界市場規模は、2017年以降年平均成長率（CAGR）4.50％で成長し、2022年には約71億3024万ドルに達した。同市場は、2022年の71億3,024万ドルから2027年には84億3,364万ドルに3.49%の成長率で拡大すると予測される。その後、2027年からCAGR 4.12%で成長し、2032年には103億2,110万ドルに達すると予想される。

歴史的期間の成長は、心血管疾患の罹患率の増加、新興市場の力強い経済成長、医薬品研究開発費の増加、医療費の増加によるものである。過去期間の成長にマイナスの影響を与えた要因は、医療意識の低さ、医療報酬の低さ、薬剤費の高騰、コロナウイルスの大流行であった。

今後は、禁煙の増加、高齢化人口の急速な増加、医療費の増加、心血管疾患の増加が成長の原動力となるだろう。今後の経皮皮膚パッチ市場の成長を阻害する要因としては、経皮皮膚パッチの副作用、厳しい規制承認、ロシア・ウクライナ戦争、金利上昇などが挙げられる。

経皮皮膚パッチ市場は製品別にマトリックス、粘着剤入り薬剤、リザーバー、蒸気に区分される。経皮皮膚パッチ市場の製品別セグメントでは、粘着剤入り薬剤市場が最大セグメントで、2022年には全体の41.49%を占めた。今後、製品別経皮皮膚パッチ市場では、リザーバーセグメントが2022-2027年のCAGR 5.36%で最も急成長すると予測されている。

経皮皮膚パッチ市場は、タイプ別にフェンタニル経皮パッチ、ニコチン経皮パッチ、エストラジオール経皮パッチ、クロニジン経皮パッチ、テストステロン経皮パッチ、その他のタイプに区分される。その他のタイプ市場は、タイプ別にセグメント化された経皮皮膚パッチ市場の最大のセグメントであり、2022年には全体の35.63％を占めた。今後、フェンタニル経皮パッチセグメントは、タイプ別にセグメント化された経皮皮膚パッチ市場において、2022-2027年のCAGRが3.75%で、最も急成長するセグメントとなる見込みである。

経皮皮膚パッチ市場は、用途別に疼痛緩和、ニコチン禁煙、ホルモン補充療法、神経疾患、心血管疾患、その他の用途に区分される。経皮皮膚パッチ市場の用途別セグメントでは、疼痛緩和市場が最大セグメントで、2022年には全体の27.35%を占めた。今後、用途別経皮皮膚パッチ市場では、ホルモン補充療法分野が2022-2027年のCAGR 5.73％で最も急成長すると予測されている。

北米は経皮皮膚パッチ市場で最大の地域であり、2022年には全体の35.22％を占めた。次いでアジア太平洋地域、その他の地域と続く。今後、経皮皮膚パッチ市場で急成長する地域は南米とアジア太平洋で、それぞれCAGR 6.60%と4.77%で成長する。

経皮吸収型テープ製剤市場は細分化されており、多数の小規模企業が存在する。同市場における上位10社の競合企業は、2021年の市場全体の24.10%を占めている。これは、特定の地域の顧客にサービスを提供する多数のローカルプレーヤーが市場に存在するためと考えられる。ノバルティスは市場シェア8.35%で最大の競合企業であり、久光製薬が6.41%でこれに続いた、が6.41％、河南菱瑞医薬が2.70％、Teva Phamaceuticalsが2.34％、Luye Pharma Group Ltd.が1.74％、Purdue Pharma L.P.が1.41％、日東電工が0.44％、AdhexPharmaが0.38％、Noven Pharmaceuticalsが0.23％、帝国製薬が0.11％となっている。

製品別にセグメント化された経皮皮膚パッチ市場における最大のビジネスチャンスは、2027年までに世界の年間売上高で6億7,059万ドルを獲得する粘着剤入り薬剤セグメントに生じるだろう。タイプ別にセグメント化された経皮皮膚パッチ市場の上位機会は、2027年までに世界年間売上高4億4,642万ドルを獲得するフェンタニル経皮パッチセグメントに生じるだろう。用途別にセグメント化された経皮皮膚パッチ市場の上位機会は、2027年までに世界年間売上高3億5,925万ドルを獲得するホルモン補充療法セグメントに生じるだろう。経皮皮膚パッチ市場規模は、米国で2億2,724万ドルと最も大きくなる。

経皮皮膚パッチ市場の市場トレンドに基づく戦略には、経皮皮膚パッチの技術的進歩、糖尿病経皮パッチの進歩、強固な研究開発活動、製品革新、共同研究やパートナーシップ、ウェアラブル皮膚パッチ、ワクチン接種用マイクロニードルパッチの進歩、新しいイオントフォレーシスパッチなどが含まれる。

経皮皮膚パッチ市場で採用されている戦略には、新製品の発売による事業運営の強化、新たな規制承認の確保による事業能力の強化などがある。

ビジネスリサーチカンパニーは、機会を活用するために、経皮皮膚パッチ企業に、経皮皮膚パッチの技術的進歩に焦点を当てること、糖尿病経皮パッチの進歩に焦点を当てること、製品イノベーションに焦点を当てること、新しいイオントフォレーシスパッチの開発に焦点を当てること、急成長している経皮パッチの種類に焦点を当てることをお勧めします、新興市場での拡大、先進国市場への注力の継続、パートナーシップと提携への注力の継続、価格競争力のある製品の提供、展示会やイベントへの参加、B2Bプロモーションの継続、急成長アプリケーションへの注力の継続、禁煙者への注力の継続、高齢化人口への注力の継続。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Transdermal Skin Patches Market Definition And Segmentations
6.4. Segmentation By Product
6.4.1. Matrix
6.4.2. Drug In Adhesive
6.4.3. Reservoir
6.4.4. Vapor
6.5. Segmentation By Type
6.5.1. Fentanyl Transdermal Patch
6.5.2. Nicotine Transdermal Patch
6.5.3. Estradiol Transdermal Patch
6.5.4. Clonidine Transdermal Patch
6.5.5. Testosterone Transdermal Patch
6.5.6. Other Types
6.6. Segmentation By Application
6.6.1. Pain Relief
6.6.2. Nicotine Cessation
6.6.3. Hormone Replacement Therapy
6.6.4. Neurological Disorders
6.6.5. Cardiovascular Disorders
6.6.6. Other Applications
7. Major Market Trends
7.1. Technological Advancement In Transdermal Skin Patches
7.2. Advancements In Diabetes Transdermal Patches
7.3. Robust Research And Development Activities
7.4. Product Innovation
7.5. Collaborations And Partnerships
7.6. Wearable Skin Patches
7.7. Advancements In Microneedle Patches for Vaccination
7.8. New Iontophoresis Patches
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Transdermal Skin Patches Market Segmentation
9.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Transdermal Skin Patches Market, Regional and Country Analysis
10.1. Global Transdermal Skin Patches Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Transdermal Skin Patches Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Transdermal Skin Patches Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Transdermal Skin Patches Market: Country Analysis
12.9. UK Market
12.10. UK Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Transdermal Skin Patches Market: Country Analysis
13.9. Russia Market
13.10. Russia Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Transdermal Skin Patches Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Transdermal Skin Patches Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Transdermal Skin Patches Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Transdermal Skin Patches Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Transdermal Skin Patches Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Transdermal Skin Patches Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Novartis AG
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Financial Overview
19.2. Hisamitsu Pharmaceutical Co., Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Henan Lingrui Pharmaceutical Co., Ltd
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Financial Overview
19.4. Teva Pharmaceuticals
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Luye Pharma Group Ltd
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers and Acquisitions
20.1. AdhexPharma Acquired tesa Labtec
20.2. Boyd Corporation Acquired MBK Tape Solutions
20.3. Nutriband Inc Acquired Pocono Coated Products
20.4. Luye Pharma Group Acquired Shandong Boan Biological Technology Co. Ltd (Boan)
20.5. Canoa Acquired ProSolus
20.6. Mylan Merged With Pfizer’s Upjohn
21. Opportunities And Strategies
21.1. Global Transdermal Skin Patches Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Transdermal Skin Patches Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Transdermal Skin Patches Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Transdermal Skin Patches Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Transdermal Skin Patches Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global transdermal skin patches market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for transdermal skin patches? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The transdermal skin patches market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider transdermal skin patches market; and compares it with other markets.

The report covers the following chapters:
•Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the transdermal skin patches market.
•Key Trends
Highlights the major trends shaping the global transdermal skin patches market. This section also highlights likely future developments in the market.
•Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
•Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
•Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by product, by type and by application in the market.
•Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
•Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
•Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
•Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
•Conclusions And Recommendations
This section includes recommendations for transdermal skin patches providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
•Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:

Markets Covered:
1) By Product: Matrix; Drug In Adhesive; Reservoir; Vapor
2) By Type: Fentanyl Transdermal Patch; Nicotine Transdermal Patch; Estradiol Transdermal Patch; Clonidine Transdermal Patch; Testosterone Transdermal Patch; Other Types
3) By Distribution Channel: Pain Relief; Nicotine Cessation; Hormone Replacement Therapy; Neurological Disorders; Cardiovascular Disorders; Other Applications

Companies Mentioned: Novartis; Hisamitsu Pharmaceutical Co., Inc; Henan Lingrui Pharmaceutical; Teva Phamaceuticals; Luye Pharma Group Ltd.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; transdermal skin patches indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report describes and explains the transdermal skin patches market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global transdermal skin patches market reached a value of nearly $7,103.24 million in 2022, having grown at a compound annual growth rate (CAGR) of 4.50% since 2017. The market is expected to grow from $7,103.24 million in 2022 to $8,433.64 million in 2027 at a rate of 3.49%. The market is then expected to grow at a CAGR of 4.12% from 2027 and reach $10,321.10 million in 2032.

Growth in the historic period resulted from the increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical R&D expenditure and increased healthcare expenditure. Factors that negatively affected growth in the historic period were low healthcare awareness, low healthcare reimbursements, high costs of drugs and the coronavirus pandemic.

Going forward, the increase in smoking cessation, the rapid growth in the aging population, the increasing healthcare expenditure and the increase in cardiovascular diseases will drive the growth. Factors that could hinder the growth of the transdermal skin patches market in the future include side effects of transdermal skin patches, stringent regulatory approvals, the Russia-Ukraine war and the rise in interest rates.

The transdermal skin patches market is segmented by product into matrix, drug in adhesive, reservoir and vapor. The drug in adhesive market was the largest segment of the transdermal skin patches market segmented by product, accounting for 41.49% of the total in 2022. Going forward, the reservoir segment is expected to be the fastest growing segment in the transdermal skin patches market segmented by product, at a CAGR of 5.36% during 2022-2027.

The transdermal skin patches market is segmented by type into fentanyl transdermal patch, nicotine transdermal patch, estradiol transdermal patch, clonidine transdermal patch, testosterone transdermal patch and other types. The other types market was the largest segment of the transdermal skin patches market segmented by type, accounting for 35.63% of the total in 2022. Going forward, the fentanyl transdermal patch segment is expected to be the fastest growing segment in the transdermal skin patches market segmented by type, at a CAGR of 3.75% during 2022-2027.

The transdermal skin patches market is segmented by application into pain relief, nicotine cessation, hormone replacement therapy, neurological disorders, cardiovascular disorders and other applications. The pain relief market was the largest segment of the transdermal skin patches market segmented by application, accounting for 27.35% of the total in 2022. Going forward, the hormone replacement therapy segment is expected to be the fastest growing segment in the transdermal skin patches market segmented by application, at a CAGR of 5.73% during 2022-2027.

North America was the largest region in the transdermal skin patches market, accounting for 35.22% of the total in 2022. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the transdermal skin patches market will be South America and Asia Pacific where growth will be at CAGRs of 6.60% and 4.77% respectively.

The transdermal skin patches market is fragmented, with a large number of small players. The top ten competitors in the market made up to 24.10% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Novartis was the largest competitor with 8.35% share of the market, followed by Hisamitsu Pharmaceutical Co., Inc with 6.41%, Henan Lingrui Pharmaceutical with 2.70%, Teva Phamaceuticals with 2.34%, Luye Pharma Group Ltd. with 1.74%, Purdue Pharma L.P. with 1.41%, Nitto Denko Corporation with 0.44%, AdhexPharma with 0.38%, Noven Pharmaceuticals with 0.23% and Teikoku Pharma with 0.11%.

The top opportunities in the transdermal skin patches market segmented by product will arise in the drug in adhesive segment, which will gain $670.59 million of global annual sales by 2027. The top opportunities in the transdermal skin patches market segmented by type will arise in the fentanyl transdermal patch segment, which will gain $446.42 million of global annual sales by 2027. The top opportunities in the transdermal skin patches market segmented by application will arise in the hormone replacement therapy segment, which will gain $359.25 million of global annual sales by 2027. The transdermal skin patches market size will gain the most in the USA at $227.24 million

Market-trend-based strategies for the transdermal skin patches market include technological advancement in transdermal skin patches, advancements in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccination and new iontophoresis patches.

Player-adopted strategies in the transdermal skin patches market include enhancing business operations through the launch of new products and strengthening business capabilities through securing new regulatory approvals.

To take advantage of the opportunities, The Business Research Company recommends the transdermal skin patches companies to focus on technological advancement in transdermal skin patches, focus on advancements in diabetes transdermal patches, focus on product innovation, focus on development of new iontophoresis patches, focus on fast-growing transdermal patch types, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to focus on fast-growing applications, focus on people quitting smoking and target the aging population.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Business Research Company　(TBRC)社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（distribution channel）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Business Research Company (TBRC)社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（distribution channel）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医療機器分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?